PeterT.SilbersteinMD

Oncology • Omaha, NE

Professor, Medicine, Creighton University School of Medicine

Join to view full profile

Dr. Silberstein is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Silberstein's full profile

Already have an account?

Office
601 N 30th St
Omaha, NE 68131
Phone+1 402-280-4364

Fax+1 402-717-0945

Education & Training

University of MinnesotaFellowship, Hematology and Medical Oncology, 1982 - 1985
University of Iowa Hospitals and ClinicsResidency, Internal Medicine, 1979 - 1982
Jacobs School of Medicine and Biomedical Sciences at the University at BuffaloClass of 1979
Amherst CollegeBA, Biophysics, Summa cum Laude, 1975

Certifications & Licensure

IA State Medical License 1979 - 2026
NE State Medical License 2002 - 2026
MN State Medical License 1982 - 1985
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

Regional Top Doctor Castle Connolly, 2014
CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2012-2013
Best Doctor in America 2005, 2007-2010, 2011
2010 VISN 23 Director’s Network Star Award 2010
Alpha Omega Alpha National Honor Medical Society, 1979
Dr. Louis A. Sklarow Award State University of New York at Buffalo Medical School, 1979
Sigma Xl, Scientific Honorary Society Amherst College, 1975
Phi Beta Kappa, Academic Honorary Society Amherst College, 1975
Dean's List 4Amherst College, 1972-1974, 1975
Join now to see all

Clinical Trials

Rituximab and Denileukin Diftitox in Treating Patients With Previously Untreated Stage III or Stage IV Follicular B-Cell Non-Hodgkin's Lymphoma Start of enrollment: 2008 Apr 01
Completed
Phase 2

Publications & Presentations

PubMed

36 citations
Association Between Race and Survival of Patients With Non–Small-Cell Lung Cancer in the United States Veterans Affairs Population
Apar Kishor Ganti, S. Subbiah, Anne Kessinger, Wilson I. Gonsalves, Peter T. Silberstein
Clinical Lung Cancer. 2014-03-01
44 citations
The epidemiology and survivorship of clear cell sarcoma: a National Cancer Database (NCDB) review
M. Isabel Gonzaga, Leah Grant, Christina Curtin, Jonathan Gootee, Peter T. Silberstein
Journal of Cancer Research and Clinical Oncology. 2018-06-30
82 citations
Epidemiology of Thyroid Cancer: A Review of the National Cancer Database, 2000-2013.
Evan Olson, Grant Wintheiser, Katrina Wolfe, Jonathan Droessler, Peter T. Silberstein
Cureus. 2019-02-24

Journal Articles

Role of Chemotherapy in The Very Elderly Patients With Metastatic Pancreatic Cancer: A Veteran’s Affairs Cancer Registry Analysis.
I. Aldoss, T. Tashi, W. Gonsalves, R. Kalaiah, P. Silberstein, A. Ganti, X. Fang, S. Subbiah, J Geriatric Oncol
Chemotherapy-induced Anemia.
Aldoss, I, Wilson, S, P. Silberstein, Asia-Pacific Oncology & Hematology
Primary Squamous Cell Carcinoma of the Lung with Bony Metastasis in a 13-year old boy:case Report and Review of literature.
Abuzetun JY, Hazin R, Suker M, P. Silberstein, A Journal of The Pediatric Hematology Oncology
Darbepoetin Alfa Adminstered Every Three Weeks is Effective for the Treatment of Chemotherapy-Induced Anemia.
Boccia R, Malik I, Raja V, Kahanic S, Liu R, Lillie T, Tomita D, Clowney B, P. Silberstein, The Oncologist
Are Blood Transfusions the Right Approach for Anemia.
P. Silberstein, Contemporary Cancer Care from Physician’s Weekly
Controlled-released oxycodone compared with controlled-release morphine in the treatment of cancer pain: a randomized, double-blind, parallel-group study.
Mucci-LoRusso P, Berman BS, P. Silberstein, Citron ML, Bressler L, Weinstein SM, Kaiko RF, Buckley BJ, Reder RF, European Journal of Pain
Inhibition of granulocyte function by steroids is not limited to corticoids, studies with sex steroids.
Hammerschmidt DE, Knabe AC, P. Silberstein, Lamche HR and Coppo PA, Inflammation
Facial burning from cyclophosphamide.
P. Silberstein, and Vercellotti GM, Cancer Treatment Reports
Hemophilic arthropathy complicated by polyarticular septic arthritis.
Goldsmith JC, P. Silberstein, Fromm RE and Walker DY, ACTA Haematologica
Nerve impulse equations: Computer solutions and displays.
P. Silberstein, Mastronarde DN and George SA, Computers and Graphics
Supernormality in single fibers of the frog's sciatic nerve. An experimental study.
P. Silberstein, Amherst College Thesis
Join now to see all

Books/Book Chapters

xPharm.
Chapter: Erythropoiesis
Peter T. Silberstein, M.DEditors: S.J. Enna and David B. Bylund.Elsevier, Inc, New York
xPharm.
Chapter: Oprelvekin
Pai Chandrashekhar, M.D., Ibrahim Aldoss, M.D., Peter T. SilbersteinEditors: S.J. Enna and David B. Bylund.Elsevier, Inc, New York
xPharm.
Chapter: Fondaparinux
Sindhu Singh, M.D., Peter T. Silberstein, M.DEditors: S.J. Enna and David B. Bylund.Elsevier, Inc, New York
xPharm.
Chapter: Sargramostim
Peter T. Silberstein, M.D., Jake BleicherEditors: S.J. Enna and David B. Bylund.Elsevier, Inc, New York
xPharm.
Chapter: Peter T. Silberstein, M.D
OprelvekinEditors: S.J. Enna and David B. Bylund.Elsevier, Inc, New York
xPharm.
Chapter: Thalassemia
Peter T. Silberstein, M.D., Nada Al-Skaf, M.DEditors: S.J. Enna and David B. Bylund.Elsevier, Inc, New York
xPharm.
Chapter: Aplastic Anemia
Peter T. Silberstein, M.D., Timothy Huyck, M.DEditors: S.J. Enna and David B. Bylund.Elsevier, Inc, New York
xPharm.
Chapter: Hemophilia
Michael White, M.D., Peter T. Silberstein, M.D., John Schrader, M.DEditors: S.J. Enna and David B. Bylund.Elsevier, Inc, New York
xPharm.
Chapter: Autoimmune Hemolytic Anemia
Peter T. Silberstein, M.D., Sowjanya Duthuluru, M.D., Shazia Zafar, M.DEditors: S.J. Enna and David B. Bylund.Elsevier, Inc, New York
xPharm.
Chapter: Pernicious Anemia
Peter T. Silberstein, M.D., Sowjanya Duthuluru, M.DEditors: S.J. Enna and David B. Bylund.Elsevier, Inc, New York
xPharm.
Chapter: Methemoglobinemia
Peter T. Silberstein, M.D., W. Michael Kutayli, M.DEditors: S.J. Enna and David B. Bylund.Elsevier, Inc, New York
xPharm.
Chapter: Iron Deficiency Anemia
Peter T. Silberstein, M.D., Adrian Caracioni, M.D., Suzanne W. Walsh, RPh, Andrew 0. WahI, M.DEditors: S.J. Enna and David B. Bylund.Elsevier, Inc, New York
xPharm.
Chapter: Idiopathic Thrombocytopenic Purpura
Peter T. Silberstein, M.D., Daniel Young, M.DEditors: S.J. Enna and David B. Bylund.Elsevier, Inc, New York
xPharm.
Chapter: Heparin Induced Thrombocytopenia
Peter T. Silberstein, M.D., Douglas H. Jones, M.DEditors: S.J. Enna and David B. Bylund.Elsevier, Inc, New York
xPharm.
Chapter: Drug-Induced Neutropenia
Peter T. Silberstein, M.D., Dharmendrakumar V. Patel, M.DEditors: S.J. Enna and David B. Bylund.Elsevier, Inc, New York
Join now to see all

Abstracts/Posters

Inpatient Outcomes and Rates of Venous Thromboembolism and Gastrointestinal Bleeding in Patients with Hepatocellular Carcinoma: Results from Nationwide Inpatient Sampl...
Peter T. Silberstein, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Angioimmunoblastic T-Cell Lymphoma: Patient Characteristics and Survival Outcomes
Peter T. Silberstein, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Epidemiology and Survival Outcomes in Elderly Acute Myeloid Leukemia Patients: An NCDB Study
Peter T. Silberstein, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Racial and Socioeconomic Disparities in the Utilization of Autologous Stem Cell Transplant for Treatment of Multiple Myeloma in the Era of Novel Agents
Peter T. Silberstein, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Primary Signet Ring Cell Carcinoma of Colon: Retrospective Analysis of VACCR database.
R. Thota, T. Tashi, W. Gonsalves, V. Murukesan, P. Townley, A. Ganti, Silberstein P, S. Subbiah, J. Clinical Oncology, Gastrointestinal Cancers Symposium. San Francisco. California
Treatment Trends of Chemotherapy Use in Metastatic Non Small Cell Lung Cancer in Veterans Affairs System.
Singh S., Silberstein P, Subbiah S, Ganti A, Association of VA Hematology/Oncology, Kansas City, MO
Racial Disparities in Colon Cancer: Retrospective Analysis of VACCR database.
N. Didwaniya, W. Gonsalves, Silberstein P, S. Subbiah, J. Clinical Oncology, San Francisco, California
Primary Non-Hodgkin’s Lymphoma of The Colon Among Patients in The Veterans Affairs Health System.
T. Tashi, R. Thota, J. Krishnamurthy, A. R. Sama, I. T. Aldoss, W. Gonsalves, A. Ganti, P. Townley, Silberstein P, S. Subbiah, J. Clinical Oncology, San Francisco, Calif
Prognostic Significance of Positive Lymph Node Ratio in Resected Esophageal Cancer.
R. Thota, T. Tashi, W. Gonsalves, A. R. Sama, Silberstein P, P. Townley, S. Subbiah, J. Clinical Oncology, ASCO Gastrointestinal Cancers Symposium
Surgical Resection in Early Limited-Stage Small Cell Lung Cancer: Time to Rethink? A Retrospective Analysis Of the VA Central Cancer Registry.
T. Tashi, I. T. Aldoss, W. Gonsalves, A. Ganti, Silberstein P, P. Townley, S. Subbiah, J. Clinical Oncology, ASCO Annual Meeting
Hodgkin Lymphoma of the Elderly Veterans: Veterans Affairs Cancer Registry Analysis.
J. Krishnamurthy, T. Tashi, W. Gonsalves, R. Thota, Silberstein P, S. Subbiah, J. Clinical Oncology, ASCO Annual Meeting
Aggressiveness of End of Life Care Before and After the Utilization of a Palliative Care Service.
W. Gonsalves, T. Tashi, T. Davies, S. Ortman, R. Thota, J. Krishnamurthy, I. T. Aldoss, M. Kalaiah, A. Ganta, N. Didwaniya, C. Eberle, A. Ganti, S. Subbiah, Silberstein P, J. Clinical Oncology, ASCO Annual Meeting
Small Cell Carcinoma of the Bladder: Analysis of Clinicopathologic Features and Survival Outcomes Among Patients in the Veterans Affairs Health System.
Wellnitz A., Tashi T, Silberstein P, Gonsalves W, Subbiah S, Kansas City, MO
VA Treatment Trends for State II Non-Small Cell Lung Carcinoma, An NCDB Analysis.
Bracha P., Silberstein P, Kansas City, MO
A Review of the Practice of Tele-Oncology in VA-NWIHCS.
Collins R., Silberstein P, Ganti A, Association of VA Hematology/Oncology, Kansas City, MO
Patterns of Care for Early Stage Prostate Cancer – Analysis of Veteran Affairs System Compared to other Systems.
Koll T., Silberstein P, Subbiah S, Ganti A, Association of VA Hematology/Oncology, Kansas City, MO
Adjuvant Chemotherapy in Stage III Colon Cancer – Retrospective Analysis of Veteran Affairs Versus Other Insurances Using NCDB Database.
Kallam A., Silberstein P, Subbiah S, Ganti A, Association of VA Hematology/Oncology, Kansas City, MO
Does Adjuvant Therapy Improve Survival in Gastric Cancer in the VA Population? A Retrospective Analysis from the VACCR Database.
T.Tashi, I. Al-Howaidi, W. Gonsalves, P. T. Silberstein, S. Subbiah, Gastrointestinal Cancers Symposium, Orlando, Florida
Survival Outcomes Based on Race in Gastric Carcinoma: A SEER database Analysis.
N. Didwaniya, R. J. Edmonds, Silberstein P, S. Subbiah, J. Clinical Oncology, San Francisco, California
TNM Staging Compared to Veterans Administration Lung Study Group Staging of Small Cell Lung Cancer-A Veterans Cancer Registry Analysis.
I. Aldoss, T. Tashi, W. Gonsalves, Silberstein P , A. Ganti, R. Thota, S. Subbiah, Multidisciplinary Symposium in Thoracic Oncology, Chicago, Illinois
Revisiting The Role of Surgery in Limited-Stage Small Cell Lung Cancer-A Retrospective Analysis of VA Cancer Registry Database.
T. Tashi, I. Aldoss, A. Ganti, Silberstein P, S. Subbiah, Multidisciplinary Symposium In Thoracic Oncology, Chicago, Illinois
Treatment and Survival Analysis of Patients 85 and Older with Non-Small Cell Lung Cancer.
R. Ranck, S. Subbiah, A. Ganti, Silberstein P, Multidisciplinary Symposium in Thoracic Oncology, Chicago, Illinois
Effect of Race on Outcomes From Non-Small Cell Lung Cancer.
A. Ganti, W. Gonsalves, I. Aldoss, P. T. Silberstein, S. Subbiah, F. Loberiza, Multidisciplinary Symposium in Thoracic Oncology, Chicago, Illinois
Number And Site of Metastases as The Predictor of Prognosis In Metastatic Colon Cancer Based on: Retrospective Study From Veteran’s Affairs Central Cancer (VACCR) Data...
R. Thota, T. Tashi, W. Gonsalves, P. T. Silberstein, S. Subbiah, American Veterans Association Hematology Oncology, Little Rock, Arkansas
Incidence and Survival of Mucinous Adenocarcinoma of The Colon: Retrospective Analysis of Veteran’s Affairs Central Cancer (VACCR) Database.
R. Thota, W. Gonsalves, T. Tashi, P. T. Silberstein, S. Subbiah, American Veterans Association Hematology Oncology, Little Rock, Arkansas
Join now to see all

Lectures

Recent Advances for the First-Line Treatment of Patients with MetastaticColorectal Cancer.
North Platte, NE
Managing Anemia.
San Antonio, TX
Targeted Therapy for Metastatic Colorectal Cancer.
Multiple locations
Chemotherapy in Early-Stage Breast Cancer.
Granger, IN
Personalized Medicine for Treatment of Lung Cancer.
Cook County Hospital – Grand Rounds, Chicago, IL
Non-small Cell Lung Cancer: Critical Choices for the Curable Patient.
Rush University Medical Center, Chicago, IL
New Approaches to Lung Cancer: Translating Clinical Research into Clinical Practice.
Hematology/Oncology Grand Rounds, University of Cincinnati, Cincinnati, OH, 2006
Insights and Treatment Strategies for Chemotherapy-Induced Nausea and Vomiting.
ONS Siouxland Regional Chapter,Sioux City, IA (CME)
Clinical Discussions in Non-Small Cell Lung Cancer.
Management of Advanced Non-Small Cell Lung Cancer.
Southwest Iowa Chapter Oncology Nursing Society, Des Moines, IA (CME)
Rituxan (Rituximab) Therapy for the First-line Treatment of Diffuse Large B-Cell, CD20-Postive Non-Hodgkin’s Lymphoma in Combination With CHOP or Other Anthracycline-B...
St. Louis, MO
Anemia and Cancer Treatment.
15th Annual Cancer Care 2006: Comprehensive Cancer Control
MDS Clinical Presentation.
Southeast Nebraska Chapter, Oncology Nursing Society, Lincoln, NE
Non-Hodgkins Lymphoma.
Chicago, IL 2009; Cedar Rapids, IA
Aranesp Dosing Flexibility in Chemotherapy Induced Anemia (CIA): 20030206 Study Update.
Amgen Oncology Regional Investigator Meeting – New York, NY
Advances in the Treatment of Colorectal Cancer.
Mercy Hospital - Des Moines, IA
The Role of Tarceva (erlotinib) in the Treatment of Locally Advanced or Metastatic NSCLC After Chemotherapy Failure.
University of New Mexico Tumor Conference – Albuquerque, NM (CME)
New Therapies for Lung Cancer.
St. Lukes Hospital – Kansas City, MO (CME)
Advances in the Treatment of Early Stage Breast Cancer.
Winner, SD
Eributex.
Sioux Falls, SD
Update on Cancer Pain.
Nebraska Coalition for Compassionate Care, Living the Good Life. At the End of Life Conference
New Advances in the Treatment of 1st Line Non-Small Cell Lung Cancer.
Deaconess Medical Center Tumor Conference, Spokane, WA
Update in Breast Cancer.
Pierre, SD and Aberdeen, SD
Advances in the Treatment of Metastatic Breast Cancer.
Multiple locations, 2003
New Advances in the Treatment of NSCLC.
Minneapolis, MN
Join now to see all